AUBOURG; Patrick

Patent Applications and Registrations

Patent applications and USPTO patent grants for AUBOURG; Patrick.The latest application filed is for "methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failure".

Company Profile

2.9.12

AUBOURG; Patrick - Le Kremlin-Bicetre FR
AUBOURG; Patrick - Le Kremlin-Bic tre FR
Aubourg; Patrick - Paris FR
Aubourg; Patrick - Granville OH
Aubourg, Patrick - Boulogne-Billancourt FR
Aubourg, Patrick - Billancourt FR
Aubourg; Patrick - Sceaux FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Pharmaceutical Compositions For The Treatment And The Prevention Of Cardiomyopathy Due To Energy Failure App 20220090128 - PUCCIO; Helene Monique ; et al.	2022-03-24
Methods And Pharmaceutical Composition For The Treatment And The Prevention Of Cardiomyopathy Due To Energy Failure App 20210340565 - PUCCIO; Helene Monique ; et al.	2021-11-04
Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the peripheral nervous system of a subject Grant 10,801,040 - Aubourg , et al. October 13, 2	2020-10-13
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia Grant 10,337,027 - Puccio , et al.	2019-07-02
Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A Subject App 20180187212 - AUBOURG; Patrick ; et al.	2018-07-05
Methods And Pharmaceutical Compositions For The Treatment And The Prevention Of Cardiomyopathy Due To Friedreich Ataxia App 20150313969 - Puccio; Helene Monique ; et al.	2015-11-05
Expression vector for cholesterol 24-hydrolase in therapy of Huntington's disease Grant 9,132,173 - Caboche , et al. September 15, 2	2015-09-15
Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia Grant 9,066,966 - Puccio , et al. June 30, 2	2015-06-30
Methods And Pharmaceutical Compositions For The Treatment Of Cardiomyopathy Due To Friedreich Ataxia App 20140221462 - Puccio; Helene Monique ; et al.	2014-08-07
Expression Vector For Cholesterol 24 -hydrolase In Therapy Of Huntington's Disease App 20130209410 - Caboche; Jocelyne ; et al.	2013-08-15
CYP46A1 gene for the treatment of alzheimer's disease Grant 8,198,257 - Aubourg , et al. June 12, 2	2012-06-12
Use of the CYP46A1 Gene for the Treatment of Alzheimer's Disease App 20110034540 - Aubourg; Patrick ; et al.	2011-02-10
Insulation system with condensate wicking for vertical applications Grant 7,308,803 - Brokaw , et al. December 18, 2	2007-12-18
Insulation system with condensate wicking for vertical applications App 20060016204 - Brokaw; Matthew C. ; et al.	2006-01-26
Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders App 20050163760 - Cartier-Lacave, Nathalie ; et al.	2005-07-28
Methods of administering vectors to synaptically connected neurons App 20050032219 - Aubourg, Patrick ; et al.	2005-02-10
Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy App 20020037902 - Aubourg, Patrick ; et al.	2002-03-28
X-linked adrenoleukodystrophy gene and corresponding protein Grant 6,013,769 - Mandel , et al. January 11, 2	2000-01-11
X-linked adrenoleukodystrophy gene and corresponding protein Grant 5,644,045 - Mandel , et al. July 1, 1	1997-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.